Compugen Ltd. | Ownership
Companies that own Compugen Ltd.
ARK Investment Management LLC
5,372,874
9.41%
1,379,123
0.69%
06/30/2018
Empery Asset Management LP
3,037,975
5.32%
3,037,975
14.33%
06/15/2018
Rock Springs Capital Management LP
1,078,165
1.89%
253,165
0.15%
06/30/2018
Morgan Stanley Smith Barney LLC (Private Banking)
970,933
1.7%
5,154
0%
06/30/2018
Great Point Partners LLC
759,494
1.33%
759,494
0.41%
06/30/2018
Taylor Frigon Capital Management LLC
666,302
1.17%
130,217
1.72%
06/30/2018
Rothschild Investment Corp.
415,451
0.73%
7,800
0.2%
06/30/2018
UBS Securities LLC
266,085
0.47%
-31,773
0%
06/30/2018
Renaissance Technologies LLC
244,900
0.43%
-35,400
0%
06/30/2018
Benjamin F. Edwards & Co., Inc.
167,600
0.28%
42,900
0.06%
06/30/2018
| Address |
Azrieli Center
Holon TA 58858
Israel
|
|
Employees
|
- |
| Website |
http://www.cgen.com |
| Updated |
07/08/2019 |
| Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |
